Obinutuzumab Intravenous and Repaglinide and Metformin Tablets
Determining the interaction of Obinutuzumab Intravenous and Repaglinide and Metformin Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: obinutuzumab
Brand name: Gazyva
Synonyms: Obinutuzumab
Generic Name: metformin / repaglinide
Brand name: PrandiMet
Synonyms: Metformin and repaglinide, Repaglinide and Metformin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Obinutuzumab Intravenous-Repaglinide Tablets
- Obinutuzumab Intravenous-Repan
- Obinutuzumab Intravenous-Repara Silver Nitrate Applicators
- Obinutuzumab Intravenous-Replace
- Obinutuzumab Intravenous-Replace Without Iron
- Obinutuzumab Intravenous-Replesta
- Repaglinide and Metformin Tablets-Obizur
- Repaglinide and Metformin Tablets-Obizur Intravenous
- Repaglinide and Metformin Tablets-Obredon
- Repaglinide and Metformin Tablets-Ocaliva
- Repaglinide and Metformin Tablets-Occlucort
- Repaglinide and Metformin Tablets-Occlusal-HP Topical